Subject: Telehealth and COVID-19 Hennepin Health update
Provider affected: All providers
Effective April 1, 2020, Hennepin Health began covering medically necessary services and consultation by providers through telephonic telemedicine in the same manner as if the service or consultation was delivered in person on an interim basis during the coronavirus (COVID-19) pandemic (Minnesota Statutes, 254B.05, subdivision 5(f) and 256B.0625, subdivision 3b).
Effective April 1, 2020, Hennepin Health included delivery of services through telephone connection between the patient and provider as part of telemedicine services. Telephone services will be allowed for the duration of the coronavirus (COVID-19) pandemic.
Hennepin Health requires providers to have submitted a Provider Assurance statement for delivery of telehealth services; we utilize the DHS provider enrollment file to verify appropriate assurance statements are in place on the date services are provided.
Providers should complete one of the following forms located on the DHS provider enrollment website and submit to provider enrollment. If you have completed form DHS-6806, you do not need to complete an additional DHS – 6806A form.
Form DHS-6806: Providers to complete this form if performing traditional telemedicine services.
Form DHS- 6806A: Providers to complete this form if they are providing telemedicine via phone with a member who is in their home, nursing home or facility.
We recommend that providers bill place of service 02 for services provided via telehealth. CPT code should represent time spent with members.
Providers are to bill Modifier 95 should only be appended to the appropriate CPT or HCPCS code when providing synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system.
Telemedicine (no restrictions during COVID-19 period)
All Hennepin Health members are eligible to receive telemedicine services.
Telemedicine services provided to members have no copays/cost sharing.
The CPT and HCPC codes that describe a telemedicine service are generally the same codes that describe an encounter when the health care provider and patient are at the same site and are billed with place of service 02.
Telemedicine services are reimbursed for both in-network and out-of-network providers without authorization.
Telemedicine payment is allowed for one reading/interpretation of diagnostic tests such as x-rays, lab test and diagnostic assessments.
All mental health services are reimbursable via telemedicine except for children’s day treatment (H2012UA), partial hospitalization (H0035/H0035UA), mental health residential treatment services (H0019).
Telehealth providers may not bill condition code DR or modifier CR on telehealth claims during the COVID-19 pandemic period. Providers must continue to use the appropriate telehealth modifiers when billing.
Per Families First Coronavirus Response Act, Hennepin Health has waived copays for services related to COVID-19 including testing, diagnostic and treatment services. There are no in-network restrictions for testing, diagnostic or treatment services.
Providers are advised bill modifier CS for specified COVID-19 testing related services that result in an order for or administration of a COVID-19 test. Lab and diagnostic services are not subject to cost sharing; this will assist in identifying physician services associated with COVID-19 lab testing billed on separate claims. Physician services billed in conjunction with lab services are not required to bill CS modifier.
Hospitalization for COVID-19 at a non-network hospital will require authorization for stays greater than 10 days. Currently, inpatient hospitalization stays at non-network hospital facilities require authorization, regardless of length of stay.
Hospitalization for COVID-19 at an in-network hospital facility will require authorization for stays greater than 10 days per current requirements.
All Hennepin Health members do not require authorization to access out-of-network providers for diagnostic testing and outpatient treatment associated with COVID-19.
Lab, pathology and radiology services are currently open access to all Hennepin Health members. Services provided by out-of-network labs and radiology departments do not require authorization to pay for services rendered.
Emergency room and urgent care services are currently open access to all Hennepin Health members (services provided by out-of-network clinics and facilities for ER and urgent care do not require authorization to pay for services rendered).
Outpatient hospital visits at non-network providers, non-emergent, will not require authorization for testing, observation and treatment based on COVID or related symptoms billed on the claim.
Hennepin Health systems have been updated to accept the following codes.
COVID-19 lab codes
CDC-2019 Novel Coronavirus Real Time RT-PCR Diagnostic Test Panel
2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19),
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified prove technique, making use of high throughput technologies as described by CMS-2020-01-R
2019nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies
Specimen collection for severe acute respiratory syndrome Coronavirus2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), from an individual in a skilled nursing facility or by a laboratory on behalf of a home health agency, any specimen source
Specimen collection for severe acute respiratory syndrome Coronavirus2 (SARS-CoV2) (Coronavirus disease [COVID-19]), any specimen source
Severe acute respiratory syndrome Coronavirus2 (SARS-CoV2) (Coronavirus disease [COVI-19])
Immunoassay for Infectious Agent Antibody(ies), Qualitative or semi-quantitative Single Step Method (e.g., Reagent Strip); Sever Acute Respiratory Syndrome Coronavirus2 (SARS-CoV1) (Coronavirus disease [COVID-19])
Antibody; Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV2) (Coronavirus disease [COVID-19])
Microbiological laboratory testing for severe acute respiratory syndrome Coronavirus2 (SARS-CoV-2)
Diagnosis code description
Provider may bill the following: